Udac, Raiven L.
HRN: 26-72-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
02/20/2025
02/27/2025
PO
1ml
TID
Oral Sores
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Eye, Ear, Nose, Throat, & MouthProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes